Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Altech – CERENERGY Environmental and Construction Approval

March 17, 2025

Crypto Market Recap: Circle, Klarna and Chime May...

April 5, 2025

Stagflation Looms: Why Economists Are Warning of a...

April 28, 2025

E-Power Resources Inc. Announces Closing of Oversubscribed Hard...

June 21, 2025

John Feneck: Key Gold, Silver Price Levels, 10+...

May 13, 2025

Inca to Raise $1.1M

April 1, 2025

Copper Prices Surpass US$10,000 as US Tariff Fears...

March 22, 2025

Right to Earn Majority Interest in Highly Prospective...

June 16, 2025

NorthStar Gaming Announces Delay of Annual Filings

April 30, 2025

Top 9 Nickel-producing Countries

June 5, 2025